VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (2)
Impact of salvage treatment phase on inotuzumab ozogamicin treatment for relapsed/refractory acute lymphoblastic leukemia: an update from the INO-VATE final study database.
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
See All 2 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia. N Engl J Med. 2016 Jan 28; 374(4):311-22.
View in:
PubMed
subject areas
Adult
Aged
Aged, 80 and over
Antineoplastic Agents
Bridged Bicyclo Compounds, Heterocyclic
Disease-Free Survival
Dose-Response Relationship, Drug
Female
Humans
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Proto-Oncogene Proteins c-bcl-2
Recurrence
Remission Induction
Sulfonamides
Tumor Lysis Syndrome
authors with profiles
WILLIAM G WIERDA